The Valley Desk

NCT00724841 · Interventional trial

A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Metastatic Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov